Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT04614298
What this trial is testing

Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Co., Ltd.
Early research (Phase 1)Study completedNCT01937260
What this trial is testing

Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT06109818
What this trial is testing

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd. 129
Large-scale testing (Phase 3)Study completedNCT01555125
What this trial is testing

First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 177
Early research (Phase 1)Looking for participantsNCT07038720
What this trial is testing

UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisHealthy Volunteer
Usynova Pharmaceuticals Ltd. 124
Large-scale testing (Phase 3)Study completedNCT03589885
What this trial is testing

Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Looking for participantsNCT07672561
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Zhejiang Wenda Pharma Technology LTD. 375
Large-scale testing (Phase 3)Study completedNCT02595970
What this trial is testing

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT05495568
What this trial is testing

To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Celltrion 367
Testing effectiveness (Phase 2)Study completedNCT00329303
What this trial is testing

Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
UCB Pharma 71
Large-scale testing (Phase 3)Looking for participantsNCT06979453
What this trial is testing

Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bristol-Myers Squibb 366
Testing effectiveness (Phase 2)Study completedNCT02908347
What this trial is testing

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Who this might be right for
PsoriasisPlaque Psoriasis
MetrioPharm AG 46
Early research (Phase 1)Study completedNCT04594928
What this trial is testing

A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Lakefront Biotherapeutics NV 30
Testing effectiveness (Phase 2)Study completedNCT02618616
What this trial is testing

Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis
Ziarco Pharma Ltd 129
Large-scale testing (Phase 3)Study completedNCT04102007
What this trial is testing

The Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab

Who this might be right for
Plaque Psoriasis
AbbVie 244
Large-scale testing (Phase 3)Study completedNCT01468207
What this trial is testing

Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa (HS)
AbbVie (prior sponsor, Abbott) 307
Testing effectiveness (Phase 2)Study completedNCT01490632
What this trial is testing

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
PsoriasisSkin DiseasesSkin Diseases, Papulosquamous
Eli Lilly and Company 271
Post-approval studies (Phase 4)Study completedNCT00686595
What this trial is testing

Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 48
Early research (Phase 1)Study completedNCT03724292
What this trial is testing

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

Who this might be right for
Psoriasis
Vitae Pharmaceuticals Inc., an Allergan affiliate 40
Early research (Phase 1)Study completedNCT05442788
What this trial is testing

HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Huabo Biopharm Co., Ltd. 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation